Showing results (221-230 of 232) with videos related to
Sort By:
Pageof 24
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Design and synthesis of 4,5-disubstituted-thiophene-2-amidines as potent urokinase inhibitorsM Jonathan Rudolph, Carl R Illig, Nalin L Subasinghe, et al.The Journal of Antibiotics|January 27, 2009
Exploring the positional attachment of glycopeptide/beta-lactam heterodimersDaniel D Long, James B Aggen, Jason Chinn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2014
A randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breastOukseub Lee, Katherine Page, David Ivancic, et al.European Urology|March 9, 2021
Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis HypothesisRachel M Glicksman, Ur Metser, Douglass Vines, et al.JAMA|January 15, 2009
Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trialMary M McDermott, Philip Ades, Jack M Guralnik, et al.Blood|October 28, 2010
Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe)Christina L Wassel, Leslie A Lange, Brendan J Keating, et al.American Journal of Hematology|March 18, 2015
Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African AmericansWeihong Tang, Mary Cushman, David Green, et al.Blood|March 7, 2009
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports projectKenneth R Carson, Andrew M Evens, Elizabeth A Richey, et al.Journal of Medicinal Chemistry|May 23, 2025
Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer TherapyDillon H Miles, Manjunath Lamani, Srinivas Reddy Paladugu, et al.Frontiers in Human Neuroscience|March 21, 2022
Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain InjuryJoshua K Wong, Günther Deuschl, Robin Wolke, et al.Pageof 24